R3 Vascular

R3 Vascular creates bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease. R3 Vascular's polymer and proprietary technologies are used to create scaffolds that balance strength and flexibility for the treatment of peripheral arterial disease. The magnitude BRS device is the thinnest BRS ever tested in this clinical setting, with a strut thickness of 98 microns across its entire usable range of diameters.

Domain

r3vascular.com

Employees

11-50

Last Funding

$87.0M

Founded

2018

Frequently Asked Questions

What technologies does R3 Vascular use?+

R3 Vascular uses 9 technologies including Adobe Fonts, Squarespace, Squarespace Commerce.

What industry is R3 Vascular in?+

R3 Vascular operates in the Health Diagnostics industry.

Where is R3 Vascular based?+

R3 Vascular is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026